Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

861
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
861
Skin Cancer01:30

Skin Cancer

5.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

4.7K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Local Anesthetics: Common Agents and Their Applications01:23

Local Anesthetics: Common Agents and Their Applications

702
Local anesthetics (LAs) are commonly used for various applications in medical and dental procedures. Some of the common agents used are cocaine, lidocaine, and bupivacaine.
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
702

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful Control of Langer hans Cell Sarcoma in a Super-Aged Patient Using Intensity-Modulated Radiotherapy.

The Journal of dermatology·2026
Same author

Three Cases of Skin Tags on the Neck Treated With a Novel and Minimally Invasive Approach Using a 2-mm Ring Curette.

The Journal of dermatology·2025
Same author

Japanese Dermatological Association Guidelines: Outlines of Japanese Guidelines for the Management of Primary Cutaneous Lymphomas 2025.

The Journal of dermatology·2025
Same author

A case of plexiform schwannoma arising in a patient with neurofibromatosis type 2.

European journal of dermatology : EJD·2025
Same author

A Case of Taxane-Induced Scleroderma Presenting in a Unilateral Upper Limb and a Literature Review.

The Journal of dermatology·2025
Same author

Diffuse Large B-Cell Lymphoma Arising in Mycosis Fungoides With Large-Cell Transformation.

The Journal of dermatology·2025

Related Experiment Video

Updated: Nov 18, 2025

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

5.9K

Topical and Systemic Formulation Options for Cutaneous T Cell Lymphomas.

Taku Fujimura1, Ryo Amagai1, Yumi Kambayashi1

  • 1Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.

Pharmaceutics
|February 5, 2021
PubMed
Summary

Established chemotherapy guidelines for cutaneous T-cell lymphoma (CTCL) are lacking. This review evaluates current CTCL treatments and ongoing clinical trials for advanced stages.

Keywords:
CTCLHDAC inhibitorsbexaroteneinterferontargeted therapytopical formulation

More Related Videos

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.8K
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

15.2K

Related Experiment Videos

Last Updated: Nov 18, 2025

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

5.9K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.8K
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

15.2K

Area of Science:

  • Oncology
  • Dermatology

Background:

  • Cutaneous T-cell lymphoma (CTCL) lacks established treatment protocols.
  • Current therapeutic options require further evaluation for optimal patient outcomes.

Purpose of the Study:

  • To review existing clinical therapies for early and advanced-stage CTCL.
  • To examine ongoing clinical trials for novel CTCL treatment regimens.

Main Methods:

  • Literature review of available CTCL therapies.
  • Analysis of ongoing clinical trials for advanced CTCL.

Main Results:

  • Various therapies including targeted therapies, HDAC inhibitors, retinoids, interferons, and cytotoxic drugs are used.
  • Numerous clinical trials are investigating novel treatment strategies.

Conclusions:

  • Further research and clinical trials are crucial for establishing definitive treatment guidelines for CTCL.
  • Optimizing therapeutic strategies is essential for improving outcomes in early and advanced CTCL.